Data Expert Discusses 9 RWE Applications in Healthcare and Pharma R&D

October 19, 2021

Vice President of Business Development & Real World Evidence (RWE) at ArborMetrix Benjamin Echeazu discusses the growing use of RWE in a wide range of applications—from drug development to tangibly improving patient outcomes. He details nine use cases where RWE and real world data (RWD) informed decision-making.

According to Echeazu, “Unlike traditional clinical trials, where necessary data elements can be curated and collection mandated, the creation of RWE requires assessing, validating and aggregating various, often disparate, sources of data available through routine clinical practice. The creation of RWE requires a combination of high-powered analytics, a validated approach and a robust knowledge of available RWD sources.” Read more here.

(Source: Benjamin Echeazu, Arbor Metrix, 8/9/21)

Share This Story!